Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-04

Clinical Trial Update: Hypogonadism in Young Men With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial investigating hypogonadism in men with type 2 diabetes; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Hypogonadotropic Hypogonadism, Type 2 Diabetes | Phase 2 | Status: TERMINATED | Results posted: 2019-10-04